Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
REGN
REGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
REGN News
Can Eli Lilly Reclaim a $1 Trillion Market Cap?
2d ago
Fool
Eli Lilly Aims to Reinstate Market Leadership Amid Competitive Landscape
2d ago
NASDAQ.COM
Regeneron Named to Dow Jones Best-in-Class Index for Six Consecutive Years
2d ago
Newsfilter
Regeneron Secures Accelerated Approval for Gene Therapy Otarmeni
2d ago
Fool
Analysis of Cash-Strong Companies
May 03 2026
Yahoo Finance
Regeneron Reports Strong Q1 Earnings Amid Eylea Sales Decline
May 02 2026
Fool
Regeneron Pharmaceuticals Reports Strong Q1 Earnings and $3B Share Buyback Plan
Apr 30 2026
Newsfilter
Regeneron Reports Strong Q1 2026 Earnings with Key Growth Drivers
Apr 29 2026
seekingalpha
Regeneron and Biogen See High Options Trading Volume
Apr 29 2026
NASDAQ.COM
Stock Price Movements of Various Companies
Apr 29 2026
CNBC
Regeneron (REGN) Q1 2026 Earnings Transcript
Apr 29 2026
NASDAQ.COM
Regeneron Reports Strong Q1 2026 Earnings and New Buyback Program
Apr 29 2026
seekingalpha
Regeneron to Host Q1 2026 Earnings Call on April 29, 2026
Apr 29 2026
NASDAQ.COM
Kiniksa Pharmaceuticals Exceeds Q1 Expectations and Raises Outlook
Apr 28 2026
seekingalpha
Intellia's CRISPR Treatment Approaches Key Phase 3 Trial Results
Apr 27 2026
stocktwits
Regeneron Offers Gene Therapy Otarmeni for Free in the U.S.
Apr 24 2026
Newsfilter
Show More News
